Medtronic (Minneapolis) received a crucial component in bringing its CoreValve system for transcatheter aortic valve implantation (TAVI) to the U.S. The med-tech giant reported last week that the FDA has given conditional approval for its investigational device exemption application and pivotal clinical trial protocol to evaluate the device.(Medical Device Daily)

Tryton Medical's (Durham, North Carolina) September momentum seems to be spilling over into this month as the company reported it has already enrolled the first patient in its E-Tryton Italy study, a registry evaluation of its Tryton Side Branch Stent System. (Medical Device Daily)